Par Drugs and Chemicals Limited (PAR.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
122
First IPO Date
May 30, 2019
| Name | Title | Pay | Year Born |
| Jignesh Vallabhbhai Savani | Chief Executive Officer & Executive Director | 5.19M | 1977 |
| Chintan Pratapbhai Chauhan | Chief Financial Officer | 677,000 | 1983 |
| Sanket Bhupendrabhai Trivedi | Company Secretary & Compliance Officer | 729,000 | 1990 |
| Falgun Vallabhbhai Savani | Chairman of the Board & MD | 5.22M | 1974 |
Par Drugs and Chemicals Limited is an Indian enterprise that focuses on the creation, production, and sale of active pharmaceutical ingredients (APIs) and specialized chemicals. Its comprehensive product line features a diverse array of compounds, such as magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, as well as various amorphous and custom-blended formulations. The company also extends its market presence through international exports. Founded in 1982, Par Drugs and Chemicals Limited is headquartered in Vadodara, India.